Feed GRAL
GR
GRAIL Inc. GRAL · NASDAQ
$143.43 -9.75% (-$15.49)
Depth
- Market cap
- $7.10B
- Enterprise value
- $7.13B
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 43.0x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -14.9%
- Gross margin
- -10.8%
- Net margin
- -236.9%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 3.25
- Free float
- 94.4%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Joshua J. Ofman
Employees
910
Headquarters
Menlo Park
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Revenue grew by 38% a year over the last 3 years.
- What speaks for it: Analysts expect revenue to grow by 23% this fiscal year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
- What to watch: The price moves much more than the market (beta 3.25).
Statements
Every number